ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 144 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $909 | -99.8% | 145,953 | +74.7% | 0.00% | 0.0% |
Q3 2022 | $559,000 | +171.4% | 83,568 | +158.0% | 0.00% | – |
Q2 2022 | $206,000 | -21.1% | 32,392 | -42.6% | 0.00% | – |
Q1 2022 | $261,000 | +44.2% | 56,427 | +55.5% | 0.00% | – |
Q4 2021 | $181,000 | -91.1% | 36,291 | -78.6% | 0.00% | -100.0% |
Q3 2021 | $2,041,000 | +257.4% | 169,400 | +527.4% | 0.00% | +100.0% |
Q2 2021 | $571,000 | -34.7% | 27,000 | +123.0% | 0.00% | 0.0% |
Q1 2018 | $875,000 | +641.5% | 12,106 | +734.9% | 0.00% | – |
Q2 2015 | $118,000 | -95.1% | 1,450 | -94.5% | 0.00% | -100.0% |
Q1 2015 | $2,430,000 | +30275.0% | 26,245 | +13022.5% | 0.01% | – |
Q4 2014 | $8,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |